Island Pharmaceuticals
Island Pharmaceuticals (ASX: ILA) is an Australian drug development company based in New South Wales, focused on addressing areas of unmet need in viral diseases with significant public health and biosecurity importance. The Company is advancing ISLA-101, a repurposed antiviral drug candidate with a well-established safety profile. ISLA-101 is being developed for the prevention and treatment of dengue fever and other mosquito-borne viral diseases, targeting large global markets where effective therapeutic options remain limited. Island’s strategy is centred on leveraging existing clinical data to accelerate development, reduce risk, and deliver meaningful outcomes in areas of high unmet medical need.
7-day free trial · no credit card
Verified contacts
3
available on Kipplo
LinkedIn employees
3
1 to 10 range
Open roles
—
no listings
Distinct roles
2
indexed titles
Tech stack
1
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 3 verified contacts at Island Pharmaceuticals
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
3 contacts with verified email or phone · masked until revealed.
Showing 1 of 3 verified contacts
Top roles at Island Pharmaceuticals
2 distinct titles indexed · top 2 shown.
- 1chief executive officer and managing director
- 1director
Sign up to unlock all 3 contacts at Island Pharmaceuticals
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 3 verified contacts at Island Pharmaceuticals
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.